These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 28672157)

  • 1. The P2X7 receptor is an upstream regulator of dynamic blebbing and a pluripotency marker in human embryonic stem cells.
    Weng NJ; Talbot P
    Stem Cell Res; 2017 Aug; 23():39-49. PubMed ID: 28672157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P2X7 receptor-dependent blebbing and the activation of Rho-effector kinases, caspases, and IL-1 beta release.
    Verhoef PA; Estacion M; Schilling W; Dubyak GR
    J Immunol; 2003 Jun; 170(11):5728-38. PubMed ID: 12759456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subcellular distribution and early signalling events of P2X7 receptors from mouse cerebellar granule neurons.
    Sánchez-Nogueiro J; Marín-García P; Bustillo D; Olivos-Oré LA; Miras-Portugal MT; Artalejo AR
    Eur J Pharmacol; 2014 Dec; 744():190-202. PubMed ID: 25446427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanical stress-induced interleukin-1beta expression through adenosine triphosphate/P2X7 receptor activation in human periodontal ligament cells.
    Kanjanamekanant K; Luckprom P; Pavasant P
    J Periodontal Res; 2013 Apr; 48(2):169-76. PubMed ID: 22881405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracellular ATP causes ROCK I-dependent bleb formation in P2X7-transfected HEK293 cells.
    Morelli A; Chiozzi P; Chiesa A; Ferrari D; Sanz JM; Falzoni S; Pinton P; Rizzuto R; Olson MF; Di Virgilio F
    Mol Biol Cell; 2003 Jul; 14(7):2655-64. PubMed ID: 12857854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic blebbing: A bottleneck to human embryonic stem cell culture that can be overcome by Laminin-Integrin signaling.
    Weng NJ; Cheung C; Talbot P
    Stem Cell Res; 2018 Dec; 33():233-246. PubMed ID: 30458343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The nucleotide receptor P2X7 mediates actin reorganization and membrane blebbing in RAW 264.7 macrophages via p38 MAP kinase and Rho.
    Pfeiffer ZA; Aga M; Prabhu U; Watters JJ; Hall DJ; Bertics PJ
    J Leukoc Biol; 2004 Jun; 75(6):1173-82. PubMed ID: 15075366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ca(2+) spiking activity caused by the activation of store-operated Ca(2+) channels mediates TNF-α release from microglial cells under chronic purinergic stimulation.
    Ikeda M; Tsuno S; Sugiyama T; Hashimoto A; Yamoto K; Takeuchi K; Kishi H; Mizuguchi H; Kohsaka SI; Yoshioka T
    Biochim Biophys Acta; 2013 Dec; 1833(12):2573-2585. PubMed ID: 23830920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping the Site of Action of Human P2X7 Receptor Antagonists AZ11645373, Brilliant Blue G, KN-62, Calmidazolium, and ZINC58368839 to the Intersubunit Allosteric Pocket.
    Bin Dayel A; Evans RJ; Schmid R
    Mol Pharmacol; 2019 Sep; 96(3):355-363. PubMed ID: 31263019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P2X7 receptors at adult neural progenitor cells of the mouse subventricular zone.
    Messemer N; Kunert C; Grohmann M; Sobottka H; Nieber K; Zimmermann H; Franke H; Nörenberg W; Straub I; Schaefer M; Riedel T; Illes P; Rubini P
    Neuropharmacology; 2013 Oct; 73():122-37. PubMed ID: 23727220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The phenothiazine-class antipsychotic drugs prochlorperazine and trifluoperazine are potent allosteric modulators of the human P2X7 receptor.
    Hempel C; Nörenberg W; Sobottka H; Urban N; Nicke A; Fischer W; Schaefer M
    Neuropharmacology; 2013 Dec; 75():365-79. PubMed ID: 23954492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The spatiotemporal relationship between local Ca(2+) signaling and P2X2R-activated membrane blebbing.
    Qudrat A; Kim JI; Truong K
    Cell Calcium; 2016 Apr; 59(4):164-71. PubMed ID: 26846906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological properties of the rhesus macaque monkey P2X7 receptor.
    Bradley HJ; Browne LE; Yang W; Jiang LH
    Br J Pharmacol; 2011 Sep; 164(2b):743-54. PubMed ID: 21457228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ATP-P2X7 Receptor Modulates Axon Initial Segment Composition and Function in Physiological Conditions and Brain Injury.
    Del Puerto A; Fronzaroli-Molinieres L; Perez-Alvarez MJ; Giraud P; Carlier E; Wandosell F; Debanne D; Garrido JJ
    Cereb Cortex; 2015 Aug; 25(8):2282-94. PubMed ID: 24610121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P2X7 nucleotide receptors mediate blebbing in osteoblasts through a pathway involving lysophosphatidic acid.
    Panupinthu N; Zhao L; Possmayer F; Ke HZ; Sims SM; Dixon SJ
    J Biol Chem; 2007 Feb; 282(5):3403-12. PubMed ID: 17135244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P2X₇-mediated calcium influx triggers a sustained, PI3K-dependent increase in metabolic acid production by osteoblast-like cells.
    Grol MW; Zelner I; Dixon SJ
    Am J Physiol Endocrinol Metab; 2012 Mar; 302(5):E561-75. PubMed ID: 22185840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P2X7 receptor antagonist activity of the anti-allergic agent oxatomide.
    Yoshida K; Ito M; Matsuoka I
    Eur J Pharmacol; 2015 Nov; 767():41-51. PubMed ID: 26463039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adipocyte P2X7 receptors expression: a role in modulating inflammatory response in subjects with metabolic syndrome?
    Madec S; Rossi C; Chiarugi M; Santini E; Salvati A; Ferrannini E; Solini A
    Atherosclerosis; 2011 Dec; 219(2):552-8. PubMed ID: 21978920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of P2X7 receptor in PC12 cells after exposure to oxygen-glucose deprivation.
    Fan B; Liu S; Xu C; Liu J; Kong F; Li G; Zhang C; Gao Y; Xu H; Yu S; Zheng C; Peng L; Song M; Wu B; Lv Q; Zou L; Ying M; Zhang X; Liang S
    Auton Neurosci; 2014 Oct; 185():36-42. PubMed ID: 24746144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility study of B16 melanoma therapy using oxidized ATP to target purinergic receptor P2X7.
    Hattori F; Ohshima Y; Seki S; Tsukimoto M; Sato M; Takenouchi T; Suzuki A; Takai E; Kitani H; Harada H; Kojima S
    Eur J Pharmacol; 2012 Nov; 695(1-3):20-6. PubMed ID: 22981895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.